| CAS ID: | 50-18-0 |
| Molecular Formula: | C7H15Cl2N2O2P |
| Molecular Weight: | 261.1 g/mol |
| Monoisotopic Mass: | 260.0248 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | CYTOXAN (LYOPHILIZED) | Neosar | Cyclophosphamide hydrate | CYTOXAN | ENDOXANA | NEOSAR | CYCLOPHOSPHAMIDE | LYOPHILIZED CYTOXAN | Cytoxan |
| Analysis: | Drug repositioning mechanism analysis |
Trial Record 1
| ClinicalTrial ID | NCT02460588 | Disease | Idiopathic pulmonary fibrosis |
| Phase | Phase 3 | Status | Recruiting |
| First Received | June 2, 2015 | Last Verified | January 3, 2018 |
| Sponsor | Assistance Publique - Hôpitaux de Paris | ||
Trial Record 2
| ClinicalTrial ID | NCT00004563 | Disease | Pulmonary fibrosis |
| Phase | Phase 3 | Status | Completed |
| First Received | February 10, 2000 | Last Verified | March 27, 2015 |
| Sponsor | The University of Texas Health Science Center, Houston | ||
Trial Record 3
| ClinicalTrial ID | NCT00004563 | Disease | Systemic scleroderma |
| Phase | Phase 3 | Status | Completed |
| First Received | February 10, 2000 | Last Verified | March 27, 2015 |
| Sponsor | The University of Texas Health Science Center, Houston | ||
Trial Record 4
| ClinicalTrial ID | NCT01570764 | Disease | Systemic sclerosis |
| Phase | Phase 3 | Status | Active, not recruiting |
| First Received | April 4, 2012 | Last Verified | March 19, 2018 |
| Sponsor | Assistance Publique - Hôpitaux de Paris | ||
Trial Record 5
| ClinicalTrial ID | NCT01570764 | Disease | Pulmonary fibrosis |
| Phase | Phase 3 | Status | Active, not recruiting |
| First Received | April 4, 2012 | Last Verified | March 19, 2018 |
| Sponsor | Assistance Publique - Hôpitaux de Paris | ||
Trial Record 6
| ClinicalTrial ID | NCT00006054 | Disease | Fibrosis |
| Phase | Not Applicable | Status | Terminated |
| First Received | July 6, 2000 | Last Verified | October 15, 2009 |
| Sponsor | Fairview University Medical Center | ||
Trial Record 7
| ClinicalTrial ID | NCT01862926 | Disease | Pulmonary fibrosis |
| Phase | Phase 2,Phase 3 | Status | Recruiting |
| First Received | May 27, 2013 | Last Verified | June 8, 2017 |
| Sponsor | Royal Brompton & Harefield NHS Foundation Trust | ||